Comment from Daniel Mulcahy
AnonymousSupportIndividual
Summary: A 100% VA-disabled veteran argues in favor of expediting the recognition of ketamine's value for treating long-term pain and treatment-resistant depression. The commenter provides personal testimony and a detailed research appendix to support the safety and efficacy of ketamine in a clinical setting compared to recreational use.
Please expedite recognition of Ketamine's value for treatment of both long-term pain, and treatment-resistant depression. I am 100% VA disabled and suffer from long-term pain due to injury to my back and neck. Ketamine is the only long-term treatment that doesn't leave me addicted to opioids, while giving me my life back.
Attachments
- Appendix 1 - Ketamine as an Addiction Agent - Copy (DOCX)
- Appendix 1 - Ketamine as an Addiction Agent - Copy (PDF)
- Appendix 2 - Ketamine for Depression with Comorbid Pain - Synthesis of Current Evidence - Copy (PDF)
- Appendix 2 - Ketamine for Depression with Comorbid Pain - Synthesis of Current Evidence - Copy (DOCX)
- Appendix 3 - Ketamine Deaths in Texas Report - Copy (PDF)
- Appendix 3 - Ketamine Deaths in Texas Report - Copy (DOCX)
- Appendix 4 - Potential New Ketamine Rule Change Costs - Copy (PDF)
- Appendix 4 - Potential New Ketamine Rule Change Costs - Copy (DOCX)
- Mulcahy - Legal Testimony Long - 7 June (DOCX)
- Mulcahy - Legal Testimony Long - 7 June (PDF)